-
Canaan Secures More Than $100M in New Biopharma Funding, Adds Former Pfizer Executive
17 Apr 2024 21:38 GMT
Pictured: Photo illustration of hundred dollar bill and graph/iStock, Darren415
Healthcare and technology-focused venture capital firm Canaan is adding $100 million in new capital to its biopharma investment funds, the company announced Wednesday.
The …
-
HER2+ Market to Accelerate Substantially by 2034, Predicts DelveInsight | Key Companies - Zymeworks, Jazz Pharmaceuticals, Ambrx, AnBogen Therapeutics, Enliven Therapeutics, Roche
17 Apr 2024 17:00 GMT
… HER2+ Companies
Zymeworks, Jazz Pharmaceuticals, Ambrx, AnBogen Therapeutics, … Roche, Ambrx, Zymeworks, Jazz Pharmaceuticals, Pfizer, among others. Metastatic HR … Oncology, Immuneering Corporation, Jacobio Pharmaceuticals, BridgeBio Pharma, Mirati Therapeutics …
-
Arvinas Strikes Deals With Pfizer, Novartis to Compete in Protein Degrader Space
17 Apr 2024 14:44 GMT
… In a 2021 deal with Pfizer worth up to $2.05 … approach the finish line. Salarius Pharmaceuticals is developing one for non … Arvinas’ deals with Novartis and Pfizer. In addition, VantAI inked a … 50-50 vepdegestrant partnership with Pfizer, Arvinas will take the U …
-
Canaan adds $100M+ to boost biopharma investing, brings on former Pfizer exec
17 Apr 2024 11:02 GMT
Canaan, a decades-old tech and life sciences venture capital firm, plans to invest more heavily in biopharma going forward.
The Menlo Park, CA-based firm added more than $100 million to its 13th fund and brought former Pfizer executive …
-
Risk adjusted net present value: What is the current valuation of Pfizer’s PF-07275315?
16 Apr 2024 18:35 GMT
… a new molecular entity.
Pfizer Overview
Pfizer discovers, develops, manufactures, … pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs) and contract manufacturing services. Pfizer … , and the Middle East. Pfizer is headquartered in New York …
-
Global Anti-Depressant Drugs Market to Register Incremental Growth by 2030, Predicts DelveInsight | Key Companies - AbbVie, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, H. Lundbeck AS, Johnson & Johnson, Pfizer
16 Apr 2024 17:00 GMT
… AS, Johnson & Johnson, Pfizer The global antidepressant drugs market … AS, Johnson & Johnson, Pfizer Inc., Organon group of companies … , AbbVie, Janssen Pharmaceuticals, Celon Pharma, ACADIA Pharmaceuticals, Pherin Pharmaceuticals, ATAI Life Sciences …
-
GSK trails after Pfizer in 5-in-1 meningococcal vaccine race
16 Apr 2024 14:33 GMT
The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.
The new vaccine is a combination of GSK’s already-approved …
-
Pfizer, BioNTech Get Legal Pause in Moderna’s COVID-19 Vaccine Patent Lawsuit
16 Apr 2024 14:09 GMT
Pictured: Roman columns at the entrance of a U.S. courthouse/iStock, Mariakray
The U.S. District Court for the District of Massachusetts has granted Pfizer and BioNTech’s motion to put on hold Moderna‘s lawsuit against the companies over alleged patent …
-
Nacuity Pharmaceuticals Expands Board of Directors with Appointment of Dr. Emmett Cunningham, Jr.
16 Apr 2024 13:00 GMT
… 2024 (GLOBE NEWSWIRE) -- Nacuity Pharmaceuticals, Inc., a clinical stage biopharmaceutical … Eyetech, Dr. Cunningham was at Pfizer, Inc. In addition, Dr. … and EverythingALS. About Nacuity Pharmaceuticals, Inc. Nacuity Pharmaceuticals, Inc. (https:/…
-
Global Geriatric Medicines Market Expected to Expand at a Steady 2024-2031 | Pfizer Inc., Cadila Pharmaceuticals, AbbVie
16 Apr 2024 06:03 GMT
… report are:
◘ Pfizer Inc.
◘ Takeda Pharmaceutical Company Limited
◘ Janssen Pharmaceuticals
◘ Sun Pharmaceutical … Health Companies
◘ Mallinckrodt Pharmaceuticals
◘ Endo Pharmaceuticals
◘ Eisai Co., Ltd.,
◘ Ferring Pharmaceuticals
◘ UCB
◘ Evoke …